Long Term Investments - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Long-Term Investments Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Long-Term Investments
zł23.4m
CAGR 3-Years
-9%
CAGR 5-Years
1%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Long-Term Investments
zł1.8m
CAGR 3-Years
126%
CAGR 5-Years
144%
CAGR 10-Years
68%
M
Medicofarma Biotech SA
WSE:MDB
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Long-Term Investments
zł63.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Long-Term Investments?
Long-Term Investments
23.4m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Long-Term Investments amounts to 23.4m PLN.

What is Ryvu Therapeutics SA's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
1%

Over the last year, the Long-Term Investments growth was 19%. The average annual Long-Term Investments growth rates for Ryvu Therapeutics SA have been -9% over the past three years , 1% over the past five years .

Back to Top